Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TRDA compared with INCY: revenue, margins and what each company keeps, and the suppliers and customers both name
TRDA
Entrada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
INCY
Incyte Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
TRDA
Entrada Therapeutics, Inc.
vs
INCY
Incyte Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TRDA, solid
INCY, dashed
TRDA
Entrada Therapeutics, Inc.
Change
4.53
· pre 4.53
· delayed
Mkt cap
$176.6M
Revenue
$898,000
Q2 FY26
Revenue
$25M
FY25
INCY
Incyte Corp
Change
120.41
· pre 120.41
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$24.5B
Revenue
$1.6B
Q3 FY26
Revenue
$5.1B
FY25
vs
Compare
Pre-market
Oct 30 '26
delayed
TRDA
Entrada Therapeutics, Inc.
vs
INCY
Incyte Corp
4.53
pre 4.53
delayed
Price
120.41
pre 120.41
delayed
$176.6M
Mkt cap
$24.5B
Q2 FY26
$898,000
Revenue
$1.6B
Q3 FY26
FY25
$25M
Revenue
$5.1B
FY25
Change
Change
TRDA
4.53
vs
INCY
120.41
Pre-market
Oct 30 '26
delayed